nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0457	0.0457	CbGpPWpGaD
Xylometazoline—HTR1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0301	0.0301	CbGpPWpGaD
Xylometazoline—HTR1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0295	0.0295	CbGpPWpGaD
Xylometazoline—ADRA1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0258	0.0258	CbGpPWpGaD
Xylometazoline—HTR1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0253	0.0253	CbGpPWpGaD
Xylometazoline—HTR1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0248	0.0248	CbGpPWpGaD
Xylometazoline—ADRA2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0233	0.0233	CbGpPWpGaD
Xylometazoline—ADRA2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0217	0.0217	CbGpPWpGaD
Xylometazoline—ADRA1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0217	0.0217	CbGpPWpGaD
Xylometazoline—ADRA1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0214	0.0214	CbGpPWpGaD
Xylometazoline—ADRA2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0196	0.0196	CbGpPWpGaD
Xylometazoline—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.019	0.019	CbGpPWpGaD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0183	0.0183	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.018	0.018	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0177	0.0177	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.016	0.016	CbGpPWpGaD
Xylometazoline—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0158	0.0158	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0148	0.0148	CbGpPWpGaD
Xylometazoline—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0131	0.0131	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0128	0.0128	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0126	0.0126	CbGpPWpGaD
Xylometazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0116	0.0116	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Other—CHRM3—nephrolithiasis	0.0114	0.0114	CbGpPWpGaD
Xylometazoline—ADRA2C—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.011	0.011	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00991	0.00991	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00925	0.00925	CbGpPWpGaD
Xylometazoline—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00896	0.00896	CbGpPWpGaD
Xylometazoline—ADRA1D—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0089	0.0089	CbGpPWpGaD
Xylometazoline—ADRA2C—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00867	0.00867	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00796	0.00796	CbGpPWpGaD
Xylometazoline—ADRA1D—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00772	0.00772	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00752	0.00752	CbGpPWpGaD
Xylometazoline—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00739	0.00739	CbGpPWpGaD
Xylometazoline—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00705	0.00705	CbGpPWpGaD
Xylometazoline—ADRA2B—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00703	0.00703	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00661	0.00661	CbGpPWpGaD
Xylometazoline—ADRA2C—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00657	0.00657	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00656	0.00656	CbGpPWpGaD
Xylometazoline—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00643	0.00643	CbGpPWpGaD
Xylometazoline—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0064	0.0064	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00587	0.00587	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00581	0.00581	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00575	0.00575	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00569	0.00569	CbGpPWpGaD
Xylometazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00569	0.00569	CbGpPWpGaD
Xylometazoline—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00534	0.00534	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00533	0.00533	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00498	0.00498	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00497	0.00497	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00487	0.00487	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00478	0.00478	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00474	0.00474	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00449	0.00449	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00439	0.00439	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.0043	0.0043	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00426	0.00426	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00424	0.00424	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00419	0.00419	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00413	0.00413	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00398	0.00398	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—RGS14—nephrolithiasis	0.0039	0.0039	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00385	0.00385	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00379	0.00379	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00375	0.00375	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00371	0.00371	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00367	0.00367	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.00362	0.00362	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.00362	0.00362	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00359	0.00359	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00354	0.00354	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—PTH—nephrolithiasis	0.00347	0.00347	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00341	0.00341	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00341	0.00341	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—PTH—nephrolithiasis	0.00339	0.00339	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00339	0.00339	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—SLC7A9—nephrolithiasis	0.00338	0.00338	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—DGKH—nephrolithiasis	0.00338	0.00338	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00324	0.00324	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00317	0.00317	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00314	0.00314	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00312	0.00312	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00308	0.00308	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.00297	0.00297	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.00296	0.00296	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00293	0.00293	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00292	0.00292	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.0029	0.0029	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00288	0.00288	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00283	0.00283	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00277	0.00277	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.00277	0.00277	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00275	0.00275	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00275	0.00275	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00274	0.00274	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.00271	0.00271	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00269	0.00269	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.00269	0.00269	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.00268	0.00268	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00263	0.00263	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00257	0.00257	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.00254	0.00254	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00251	0.00251	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.0025	0.0025	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.00246	0.00246	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00239	0.00239	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.00237	0.00237	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.00235	0.00235	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00234	0.00234	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—RGS14—nephrolithiasis	0.0023	0.0023	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.0023	0.0023	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00229	0.00229	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00222	0.00222	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00219	0.00219	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00214	0.00214	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00214	0.00214	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00214	0.00214	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.0021	0.0021	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0021	0.0021	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00208	0.00208	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.00203	0.00203	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.00203	0.00203	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.00201	0.00201	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.002	0.002	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.00197	0.00197	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.00196	0.00196	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.00195	0.00195	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.00194	0.00194	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00192	0.00192	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00191	0.00191	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.0019	0.0019	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00187	0.00187	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00183	0.00183	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.00182	0.00182	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.00181	0.00181	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.00178	0.00178	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00175	0.00175	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.00174	0.00174	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00174	0.00174	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.0017	0.0017	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.0017	0.0017	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.00168	0.00168	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.00167	0.00167	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.00166	0.00166	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00166	0.00166	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00165	0.00165	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00162	0.00162	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.00159	0.00159	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00159	0.00159	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00158	0.00158	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00155	0.00155	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—APRT—nephrolithiasis	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00151	0.00151	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.0015	0.0015	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00148	0.00148	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.00147	0.00147	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.00141	0.00141	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.0014	0.0014	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00139	0.00139	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.00137	0.00137	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00135	0.00135	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.00128	0.00128	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.00126	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00126	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.00125	0.00125	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APRT—nephrolithiasis	0.00125	0.00125	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00124	0.00124	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00114	0.00114	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00113	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.00113	0.00113	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.00113	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.0011	0.0011	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.00105	0.00105	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.00104	0.00104	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.00103	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.001	0.001	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.001	0.001	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000992	0.000992	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000984	0.000984	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000932	0.000932	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000932	0.000932	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.0009	0.0009	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000891	0.000891	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000888	0.000888	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000829	0.000829	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000816	0.000816	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000812	0.000812	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000806	0.000806	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.000759	0.000759	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000747	0.000747	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000725	0.000725	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000674	0.000674	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000663	0.000663	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000616	0.000616	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.000528	0.000528	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000517	0.000517	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	0.000452	0.000452	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	0.000408	0.000408	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	0.000381	0.000381	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000375	0.000375	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000333	0.000333	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000309	0.000309	CbGpPWpGaD
